ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services
Chicago, IL, August 23, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions...
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook A Customer-Centric Approach to Clinical Research Solutions ProPharma Group is honored to be named Top 10 CRO 2022 by Pharma Tech Outlook...
ProPharma Group Announces the Acquisition of M Squared Associates
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm...
ProPharma Group and The Planet Group Announce Executive Leadership Changes and Branding of Combined Company
ProPharma Group, a portfolio company of Odyssey Investment Partners, is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical,...
ProPharma Group Announces the Acquisition of iSafety Systems
ProPharma Group Announces the Acquisition of iSafety Systems: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of iSafety Systems. Headquartered in...
Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, Joins NDA Partners as Expert Consultant
NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...
ProPharma Group and The Planet Group Announce Agreement to Merge
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...
ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...